Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

Clinical trial NCT04781140 · RECRUITING

Trial details

NCT number: NCT04781140
Sponsor: Supernus Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Attention-Deficit/Hyperactivity Disorder

Start date: 2024-03-19
Primary completion: 2026-06-01
Enrollment: 286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.